{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:26:20Z","timestamp":1794885980047,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biomaterials.2025.123100","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:33:03Z","timestamp":1736397183000},"page":"123100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Bioresponsive nanoreactor initiates cascade reactions for tumor vascular normalization and lactate depletion to augment immunotherapy"],"prefix":"10.1016","volume":"317","author":[{"given":"Jiaoyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxin","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9803-6487","authenticated-orcid":false,"given":"Sheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123100_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123100_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123100_bib3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123100_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123100_bib5","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd.2018.210","article-title":"Trial watch: the clinical trial landscape for PD1\/PDL1 immune checkpoint inhibitors","author":"Tang","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2025.123100_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41563-023-01515-2","article-title":"Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy","volume":"22","author":"Shin","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123100_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2025.123100_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2025.123100_bib10","first-page":"e13","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2025.123100_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment","volume":"13","author":"Smyth","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123100_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aaw7875","article-title":"Vascular regulation of antitumor immunity","volume":"365","author":"Munn","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123100_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2025.123100_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s44222-022-00004-6","article-title":"Biomaterials tools to modulate the tumour microenvironment in immunotherapy","volume":"1","author":"Chao","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.biomaterials.2025.123100_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Glycolysis preserves T cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2025.123100_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejca.2022.11.032","article-title":"Rationale for LDH-targeted cancer immunotherapy","volume":"181","author":"Miholjcic","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123100_bib18","doi-asserted-by":"crossref","first-page":"16934","DOI":"10.1021\/acsnano.1c08026","article-title":"Metal-phenolic network-enabled lactic acid consumption reverses immunosuppressive tumor microenvironment for sonodynamic therapy","volume":"15","author":"Zhang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123100_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2712","article-title":"Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy","volume":"15","author":"Cao","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2025.123100_bib20","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1021\/jacs.3c02005","article-title":"Nitrogen-centered lactate oxidase nanozyme for tumor lactate modulation and microenvironment remodeling","volume":"145","author":"Zhao","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2025.123100_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122089","article-title":"Photothermal \u201cnano-dot\u201d reactivate \u201cimmune-hot\u201d for tumor treatment via reprogramming cancer cells metabolism","volume":"296","author":"Lu","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123100_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122205","article-title":"Tumor microenvironment-initiated lipid redox cycling for efficient triple-negative breast cancer therapy","volume":"300","author":"Zhou","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123100_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12951-022-01762-6","article-title":"Lactate oxidase\/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth","volume":"21","author":"Choi","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123100_bib24","doi-asserted-by":"crossref","first-page":"nwaa160","DOI":"10.1093\/nsr\/nwaa160","article-title":"Advances in nanomaterials for treatment of hypoxic tumor","volume":"8","author":"Zou","year":"2021","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.biomaterials.2025.123100_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207650","article-title":"The combination of R848 with sorafenib enhances antitumor effects by reprogramming the tumor immune microenvironment and facilitating vascular normalization in hepatocellular carcinoma","volume":"10","author":"He","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123100_bib26","article-title":"Normalization of tumor vessels by lenvatinib-based metallo-nanodrugs alleviates hypoxia and enhances calreticulin-mediated immune responses in orthotopic HCC and organoids","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123100_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122550","article-title":"Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy","volume":"308","author":"Wu","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123100_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-023-43743-9","article-title":"TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer","volume":"15","author":"Lv","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123100_bib29","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1073\/pnas.1919764117","article-title":"Combining microenvironment normalization strategies to improve cancer immunotherapy","volume":"117","author":"Mpekris","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2025.123100_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123100_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123100_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202202625","article-title":"Supramolecular nitric oxide depot for hypoxic tumor vessel normalization and radiosensitization","volume":"34","author":"Yang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib33","article-title":"A Self-catalytic NO\/O2 gas-releasing nanozyme for radiotherapy sensitization through vascular normalization and hypoxia relief","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41565-019-0570-3","article-title":"Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies","volume":"14","author":"Sung","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123100_bib35","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1021\/acsnano.2c03348","article-title":"Nanostructured organosilica nitric oxide donors intrinsically regulate macrophage polarization with antitumor effect","volume":"16","author":"Theivendran","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123100_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.matt.2019.07.007","article-title":"Cerenkov luminescence-induced NO release from 32P-Labeled ZnFe(CN)5NO nanosheets to enhance radioisotope-immunotherapy","volume":"1","author":"Tian","year":"2019","journal-title":"Matter"},{"key":"10.1016\/j.biomaterials.2025.123100_bib37","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1021\/acsnano.2c10352","article-title":"Biomineralized MnO2 nanoplatforms mediated delivery of immune checkpoint inhibitors with sting pathway activation to potentiate cancer radio-immunotherapy","volume":"17","author":"Deng","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123100_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202109213","article-title":"Neisseria meningitidis opca protein\/MnO2 hybrid nanoparticles for overcoming the blood\u2013brain barrier to treat glioblastoma","volume":"34","author":"Dong","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","article-title":"Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123100_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904639","article-title":"Intra\/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors","volume":"31","author":"Gao","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib41","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1002\/adfm.201602541","article-title":"A red light activatable multifunctional prodrug for image-guided photodynamic therapy and cascaded chemotherapy","volume":"26","author":"Liu","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121593","article-title":"A self-delivery chimeric peptide for high efficient cell membrane-targeting low-temperature photothermal\/photodynamic combinational therapy and metastasis suppression of tumor","volume":"286","author":"Chen","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123100_bib43","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41467-018-03233-9","article-title":"Optically-controlled bacterial metabolite for cancer therapy","volume":"9","author":"Zheng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123100_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ccr.2013.12.010","article-title":"Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption","volume":"25","author":"Kim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2025.123100_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"issue":"n\/a","key":"10.1016\/j.biomaterials.2025.123100_bib46","article-title":"Engineered biomimetic cancer cell membrane nanosystems trigger gas-immunometabolic therapy for spinal-metastasized tumors","author":"Lu","year":"2024","journal-title":"Adv. Mater. n\/a"},{"key":"10.1016\/j.biomaterials.2025.123100_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123100_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.139506","article-title":"Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis","volume":"452","author":"Feng","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2025.123100_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb0020","article-title":"Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption","volume":"6","author":"Hong","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123100_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add1153","article-title":"STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy","volume":"8","author":"Wang-Bishop","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123100_bib51","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06256-5","article-title":"Reprogramming tumour-associated macrophages to outcompete cancer cells","volume":"619","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2025.123100_bib52","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123100_bib53","article-title":"A tumor microenvironments-adapted polypeptide hydrogel\/nanogel composite boosts antitumor molecularly targeted inhibition and immunoactivation","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123100_bib54","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41467-023-39035-x","article-title":"Nanovesicles loaded with a TGF-beta receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T19:22:32Z","timestamp":1740338552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"alternative-id":["S0142961225000195"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123100","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioresponsive nanoreactor initiates cascade reactions for tumor vascular normalization and lactate depletion to augment immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"123100"}}